Literature DB >> 12437273

The development of a simulation model of the treatment of coronary heart disease.

Keith Cooper1, Ruth Davies, Paul Roderick, Debbie Chase, James Raftery.   

Abstract

A discrete event simulation models the progress of patients who have had a coronary event, through their treatment pathways and subsequent coronary events. The main risk factors in the model are age, sex, history of previous events and the extent of the coronary vessel disease. The model parameters are based on data collected from epidemiological studies of incidence and prognosis, efficacy studies. national surveys and treatment audits. The simulation results were validated against different sources of data. The initial results show that increasing revascularisation has considerable implications for resource use but has little impact on patient mortality.

Entities:  

Mesh:

Year:  2002        PMID: 12437273     DOI: 10.1023/a:1020378022303

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  21 in total

1.  Projecting coronary heart disease incidence and cost in Australia: results from the incidence module of the Cardiovascular Disease Policy Model.

Authors:  S L Mui
Journal:  Aust N Z J Public Health       Date:  1999-02       Impact factor: 2.939

2.  Pathways of coronary care--a computer-simulation model of the potential for health gain.

Authors:  D C Bensley; P S Watson; G W Morrison
Journal:  IMA J Math Appl Med Biol       Date:  1995 Sep-Dec

3.  Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.

Authors:  M C Weinstein; P G Coxson; L W Williams; T M Pass; W B Stason; L Goldman
Journal:  Am J Public Health       Date:  1987-11       Impact factor: 9.308

4.  POHEM--a framework for understanding and modelling the health of human populations.

Authors:  M C Wolfson
Journal:  World Health Stat Q       Date:  1994

5.  Expected gains in life expectancy from various coronary heart disease risk factor modifications.

Authors:  J Tsevat; M C Weinstein; L W Williams; A N Tosteson; L Goldman
Journal:  Circulation       Date:  1991-04       Impact factor: 29.690

6.  Presentation, management and course of angina and suspected angina in primary care.

Authors:  D Gill; R Mayou; M Dawes; D Mant
Journal:  J Psychosom Res       Date:  1999-04       Impact factor: 3.006

7.  Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.

Authors: 
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

8.  Exercise testing without interruption of medication for refining the selection of mildly symptomatic patients for prognostic coronary angiography.

Authors:  R Lim; I Kreidieh; L Dyke; J Thomas; D S Dymond
Journal:  Br Heart J       Date:  1994-04

9.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.

Authors:  D J Lerner; W B Kannel
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

10.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

View more
  15 in total

Review 1.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

Review 2.  Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment.

Authors:  Syed Salleh; Praveen Thokala; Alan Brennan; Ruby Hughes; Simon Dixon
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

3.  The development of a simulation model of primary prevention strategies for coronary heart disease.

Authors:  Hannah Babad; Colin Sanderson; Bhash Naidoo; Ian White; Duolao Wang
Journal:  Health Care Manag Sci       Date:  2002-11

4.  A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Authors:  James G Xenakis; Elizabeth T Kinter; K Jack Ishak; Alexandra J Ward; Jeno P Marton; Richard J Willke; Simon Davies; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

Review 5.  Systematic review of the use of computer simulation modeling of patient flow in surgical care.

Authors:  Boris G Sobolev; Victor Sanchez; Christos Vasilakis
Journal:  J Med Syst       Date:  2009-07-07       Impact factor: 4.460

6.  Cost estimation of cardiovascular disease events in the US.

Authors:  Amy K O'Sullivan; Jaime Rubin; Joshua Nyambose; Andreas Kuznik; David J Cohen; David Thompson
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

7.  Using simulation to estimate the cost effectiveness of improving ambulance and thrombolysis response times after myocardial infarction.

Authors:  D Chase; P Roderick; K Cooper; R Davies; T Quinn; J Raftery
Journal:  Emerg Med J       Date:  2006-01       Impact factor: 2.740

8.  Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications.

Authors:  Shien Guo; Duygu Bozkaya; Alexandra Ward; Judith A O'Brien; Khajak Ishak; Randy Bennett; Ahmad Al-Sabbagh; Dennis M Meletiche
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000.

Authors:  Luigi Palmieri; Kathleen Bennett; Simona Giampaoli; Simon Capewell
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

10.  Evaluation of booking systems for elective surgery using simulation experiments.

Authors:  Boris G Sobolev; Victor Sanchez; Lisa Kuramoto; Adrian R Levy; Martin Schechter; J Mark Fitzgerald
Journal:  Healthc Policy       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.